United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2012_register executive 2012-08-09 article Rules and Regulations D09002ee1c7fc9ca2 D09002ee1c7fc9d8f United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during June 2012. FDA is also informing the public of the availability of summaries the basis of approval and of environmental review documents, where applicable. 77 FR 47511 https://www.govinfo.gov/app/details/FR-2012-08-09/2012-19498 2012-19498 fr09au12-1 4160-01-P Docket No. FDA-2012-N-0002 https://www.govinfo.gov/app/details/FR-2012-08-09/2012-19498 https://www.govinfo.gov/content/pkg/FR-2012-08-09/html/2012-19498.htm https://www.govinfo.gov/content/pkg/FR-2012-08-09/pdf/2012-19498.pdf Administrative Practice and Procedure Animal Drugs Labeling Reporting and Recordkeeping Requirements 2 p. 47511 47512 77 FR 47511 Title 21 Part 510 21 CFR Part 510 Title 21 Part 520 21 CFR Part 520 Title 21 Part 524 21 CFR Part 524 New Animal Drugs; Cephalexin; Fentanyl; Milbemycin Oxime and Praziquantel; Federal Register Vol. 77, Issue RULE 2012-19498 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 2012-08-09 Docket No. FDA-2012-N-0002 4160-01-P 2012-19498 Final rule.

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during June 2012. FDA is also informing the public of the availability of summaries the basis of approval and of environmental review documents, where applicable.

This rule is effective August 9, 2012. George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9019, email: george.haibel@fda.hhs.gov. Administrative Practice and Procedure Animal Drugs Labeling Reporting and Recordkeeping Requirements New Animal Drugs: Cephalexin; Fentanyl; Milbemycin Oxime and Praziquantel , george.haibel@fda.hhs.gov http://www.fda.gov/AboutFDA/CentersOffices/OfficeofFoods/CVM/CVMFOIAElectronicReadingRoom/default.htm Vol. 77, no. 154 Office of the Federal Register, National Archives and Records Administration 2012-08-09 continuing daily deposited born digital 264 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2012-08-09 P0b002ee1833aba95 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr09au12 https://www.govinfo.gov/app/details/FR-2012-08-09 https://www.govinfo.gov/content/pkg/FR-2012-08-09/pdf/FR-2012-08-09.pdf https://www.govinfo.gov/content/pkg/FR-2012-08-09/xml/FR-2012-08-09.xml fdlp 47511 47766 DGPO 2012-08-09 2024-06-03 FR-2012-08-09 machine generated eng FR FR-2012-08-09 77 154